Basic Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 7, 2008; 14(17): 2731-2739
Published online May 7, 2008. doi: 10.3748/wjg.14.2731
Table 1 Analytical data in the three experimental groups before and after treatment
CO, healthy control groupCI, untreated cirrhotic groupCI + IGF-I, cirrhotic rats treated with IGF-I
Aspartate transaminase (IU/L)d 075.0 ± 5.0142.0 ± 35.0150.0 ± 24.0
d 3086.0 ± 4.0168.0 ± 29.0b128.0 ± 15.0c
Alanine transaminase (IU/L)d 034.0 ± 1.069.0 ± 10.0b73.0 ± 10.0b
d 3033.0 ± 2.058.0 ± 7.0b58.0 ± 9.0bc
Alkaline phosphatase (IU/L)d 063.0 ± 4.0110.0 ± 14.0a124.0 ± 21.0a
d 3060.0 ± 2.0100.0 ± 12.0b77.0 ± 8.0c
Billirubin (mg/dL)d 00.1 ± 0.10.4 ± 0.2a0.4 ± 0.1a
d 300.1 ± 0.00.3 ± 0.10.2 ± 0.1c
Cholesterol (mg/dL)d 049.0 ± 4.076.0 ± 5.0b80.0 ± 7.0b
d 3046.0 ± 2.061.0 ± 9.057.0 ± 5.0c
Triglycerides (mg/dL)d 0151.0 ± 22.0119.0 ± 6.0101.0 ± 11.0
d 30102.0 ± 12.082.0 ± 11.070.0 ± 7.0
Glucose (mmol/L)d 011.32 ± 0.636.97 ± 0.43b6.45 ± 0.51b
d 309.27 ± 0.346.4 ± 0.45b7.45 ± 0.32bc
Albumin (g/dL)d 03.6 ± 0.13.4 ± 0.13.4 ± 0.1
d 303.8 ± 0.13.5 ± 0.23.7 ± 0.1
Total proteins (mmol/L)d 06.9 ± 0.16.6 ± 0.26.5 ± 0.1
d 306.8 ± 0.86.2 ± 0.36.6 ± 0.1